Authors: SCHULMAN KA DORSAINVIL D YABROFF KR DICESARE J FELSER J EISENBERG JM GLICK HA

Citation: Ka. Schulman et al., PROSPECTIVE ECONOMIC-EVALUATION ACCOMPANYING A TRIAL OF GM-CSF IL-3 IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HODGKINS AND NON-HODGKINS-LYMPHOMA/, Bone marrow transplantation, 21(6), 1998, pp. 607-614

Authors: BUDD GT SAMUELS B GOCKERMAN J BAKER L MARGOLIN K ZALUPSKI M FELSER J JOHNSON B ISAACS R BUKOWSKI RM

Citation: Gt. Budd et al., RANDOMIZED TRIAL OF MAID (MESNA, ADRIAMYCIN, IFOSFAMIDE, DECARBAZINE)CHEMOTHERAPY WITH G-CSF ALONE OR WITH G-CSF PLUS VARYING DOSES OF INTERLEUKIN-6 (IL-6), Blood, 88(10), 1996, pp. 3281-3281

Authors: WOLFF SN AHMED T VANBESIEN K SCHUSTER M CHAMPLIN R STEIN RS GREER JP DICESARE J FELSER J

Citation: Sn. Wolff et al., SIMULTANEOUS AND SEQUENTIAL RHIL-3 (SDZ ILE 964) AND RHG-CSF (NEUPOGEN) POST AUTOLOGOUS BONE-MARROW TRANSPLANTATION NABMT) FOR LYMPHOMA - APHASE-I-II STUDY, Blood, 82(10), 1993, pp. 10000287-10000287

Authors: FAY JW FELSER J LAZARUS HM HERZIG R SAEZ R STEVENS D COLLINS RH PINERO L COOPER B HERZIG GP CAMPION M DICESARE J BERNSTEIN SH

Citation: Jw. Fay et al., SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 (RHIL-3) AND RHGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - AN UPDATE OF THE PHASE-I II TRIAL/, Blood, 82(10), 1993, pp. 10000287-10000287